Page last updated: 2024-09-04

tariquidar and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester

tariquidar has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 3 studies

Compound Research Comparison

Studies
(tariquidar)
Trials
(tariquidar)
Recent Studies (post-2010)
(tariquidar)
Studies
(3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester)
Trials
(3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester)
Recent Studies (post-2010) (3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester)
2101613869061

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klinkhammer, W; Pick, A; Wiese, M1
Bankstahl, JP; Bankstahl, M; Erker, T; Filip, T; Kuntner, C; Langer, O; Löscher, W; Mairinger, S; Müller, M; Sauberer, M; Stanek, J; Wanek, T1
Altmann, KH; Bartholomaeus, R; Bauer, S; Bause, M; Bernhardt, G; Buschauer, A; Jackson, SM; Koenig, B; Kowal, J; Locher, KP; Manolaridis, I; Stahlberg, H; Taylor, NMI; Zechner, M1

Other Studies

3 other study(ies) available for tariquidar and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester

ArticleYear
Specific inhibitors of the breast cancer resistance protein (BCRP).
    ChemMedChem, 2010, Sep-03, Volume: 5, Issue:9

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Diketopiperazines; Drug Resistance, Multiple; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Imatinib Mesylate; Indoles; Neoplasm Proteins; Novobiocin; Piperazines; Pyrimidines; Quinolines; Structure-Activity Relationship

2010
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:11

    Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Data Interpretation, Statistical; Diketopiperazines; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals

2012
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.
    Nature structural & molecular biology, 2018, Volume: 25, Issue:4

    Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily G, Member 2; Binding Sites; Cholesterol; Cryoelectron Microscopy; Diketopiperazines; Drug Design; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrolysis; Indoles; Kinetics; Lipids; Molecular Structure; Neoplasm Proteins; Phospholipids; Protein Binding; Protein Multimerization; Quinolines; Structure-Activity Relationship; Substrate Specificity

2018